Key Highlights
- Blackstone plans to establish a publicly listed entity dedicated to acquiring AI data center assets, with ambitions to raise capital in the tens of billions
- Initial fundraising efforts will concentrate on attracting commitments from sovereign wealth funds alongside institutional capital sources
- Both Blackstone and Brookfield have presented proposals exceeding €8 billion to acquire Volkswagen’s Everllence SE, which specializes in heavy diesel engine manufacturing
- A collaborative funding arrangement between Blackstone Life Sciences and Johnson & Johnson will support development of bleximenib, an experimental treatment for AML cancer
- On February 23, RBC Capital began covering the stock with an Outperform designation and established a $179 valuation benchmark
The global investment management firm has revealed plans for a publicly listed acquisition platform designed to purchase AI data center properties. This initiative aims to open access to AI infrastructure investments for individual retail participants—a sector where Blackstone seeks commanding market presence.
Initial capital formation will draw from sovereign wealth funds and large institutional backers. Following this phase, the company intends to expand fundraising efforts to attract tens of billions from a wider investor audience.
The strategy represents significant ambition. Questions about optimal timing persist among market observers.
Certain investors have expressed skepticism regarding large-scale AI training complexes constructed in remote locations, citing potential obsolescence risks as technology advances. Blackstone’s initiative directly addresses these industry discussions.
This development aligns with the firm’s expanded vision to reach beyond conventional client relationships with pension funds and endowment institutions. Individual investors represent an increasingly important target demographic.
Volkswagen Asset Acquisition
Regarding transaction activity, Blackstone and Brookfield Asset Management (NYSE: BAM) have each presented offers valued at minimum €8 billion ($9.4 billion) to acquire controlling ownership in Volkswagen’s Everllence SE division.
Everllence manufactures marine propulsion systems and power generation turbines. Volkswagen has pursued divestment of this business segment as part of organizational restructuring designed to enhance operational efficiency and financial performance.
Additional competing bidders include Advent International, Bain Capital, EQT AB, and CVC Capital Partners—all have progressed to subsequent negotiation stages.
Transaction completion remains uncertain. Sources cited by Bloomberg indicate ongoing deliberations continue.
Pharmaceutical Partnership and Market Analysis
February 23 brought announcement of a co-funding partnership between Blackstone Life Sciences and Johnson & Johnson to support clinical trials of bleximenib, an oral investigational medication designed to treat acute myeloid leukemia.
AML represents the most prevalent acute leukemia diagnosis among adult patients and carries the poorest survival statistics across all leukemia classifications. Company leadership characterized the disease as presenting extraordinary therapeutic challenges.
This marks the inaugural co-funding collaboration between BXLS and Johnson & Johnson, representing a significant development for Blackstone’s life sciences division.
That same date, RBC Capital commenced coverage of Blackstone shares with an Outperform assessment and assigned a $179 price objective.
RBC communicated to investors that Blackstone maintains a “first-mover advantage” as the inaugural alternatives manager to establish a dedicated private wealth division. The financial institution positions the firm as a long-duration beneficiary of expanding retail investor participation and stabilizing commercial real estate conditions.
Blackstone conducts operations through four primary business lines: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions.
BX shares declined 3.88% on February 27, coinciding with publication of news regarding the AI data center platform and Volkswagen transaction proposals.
